http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100497603-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c66b639a68381f72d2daae43501c5ebd |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10151 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08 |
| filingDate | 2007-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f34ca25471b47a597852d0c2397f0b00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7537b47b7703705d8376d495789b77f2 |
| publicationDate | 2009-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-100497603-C |
| titleOfInvention | Use of liver cell line QSG-7701 for infecting hepatitis B virus |
| abstract | The invention relates to HBV infection with hepatocyte QSG-7701, comprising following steps: direct infection of HBV virus particle in HBV positive or purified serum with cultured QSG-7701, treating with DMSO or adding PEG for infection assistance. The invention is characterized in that the hepatocyte QSG-7701 is easy to get, the infection of HBV needs no predifferentiation and introduction, which is more near to HBV- infected hepatocyte condition in human body. It is suited for research of HBV life circle, especially research of infection process and medicine for relative target. |
| priorityDate | 2007-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.